Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinson's disease and other neurodegenerative diseases in Australia. The company is headquartered in Melbourne, Australia.
52W High
$7.00
52W Low
$1.00
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.36
Valuation
As of 2024-12-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.76
EV/Revenue (<3 favorable)
113.99
P/S (TTM) (<3 favorable)
14.35
P/B (<3 favorable)
2.80
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
1.45%
Shares Outstanding
15,347,900
Float
7,476,216,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2024-12-31 (Overview)
Revenue (TTM)
5,438,900
Gross Profit (TTM)
5,311,400
EPS (TTM)
-0.75
Profit Margin (>10% good)
-2.23%
Operating Margin (TTM) (higher better)
-1.86%
ROE (TTM) (>15% strong)
-0.43%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.81
Momentum
Bearish momentumValue
-0.0097
Previous
0.0055
Trend
Falling
Signal Cross
No cross
As of
Sep. 11, 2025